Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CADL |
---|---|---|
09:32 ET | 2832 | 6.8 |
09:36 ET | 515 | 6.87 |
09:38 ET | 3457 | 6.7248 |
09:39 ET | 2100 | 6.8473 |
09:41 ET | 100 | 6.795 |
09:48 ET | 228 | 6.8042 |
09:50 ET | 200 | 6.8338 |
09:54 ET | 1200 | 6.79 |
09:56 ET | 200 | 6.761 |
09:57 ET | 300 | 6.71 |
09:59 ET | 198 | 6.6806 |
10:01 ET | 9279 | 6.6158 |
10:03 ET | 1930 | 6.62 |
10:06 ET | 7337 | 6.59 |
10:08 ET | 12608 | 6.46 |
10:10 ET | 5018 | 6.55 |
10:12 ET | 3912 | 6.51 |
10:14 ET | 7191 | 6.485 |
10:15 ET | 1200 | 6.535 |
10:17 ET | 100 | 6.58 |
10:19 ET | 640 | 6.63 |
10:21 ET | 400 | 6.6656 |
10:24 ET | 5667 | 6.63 |
10:26 ET | 9008 | 6.55 |
10:28 ET | 1288 | 6.58 |
10:32 ET | 600 | 6.5844 |
10:33 ET | 726 | 6.52 |
10:37 ET | 10612 | 6.5 |
10:39 ET | 2300 | 6.47 |
10:42 ET | 162 | 6.4777 |
10:44 ET | 1208 | 6.5 |
10:46 ET | 900 | 6.4701 |
10:48 ET | 1628 | 6.52 |
10:53 ET | 300 | 6.4801 |
10:55 ET | 2802 | 6.5199 |
10:57 ET | 293 | 6.53 |
11:00 ET | 151 | 6.5347 |
11:02 ET | 1300 | 6.53 |
11:08 ET | 300 | 6.585 |
11:11 ET | 2800 | 6.6257 |
11:20 ET | 250 | 6.615 |
11:22 ET | 300 | 6.57 |
11:24 ET | 200 | 6.5401 |
11:27 ET | 100 | 6.54 |
11:36 ET | 527 | 6.56 |
11:42 ET | 100 | 6.575 |
11:44 ET | 300 | 6.59 |
11:45 ET | 3400 | 6.56 |
11:56 ET | 100 | 6.575 |
12:02 ET | 400 | 6.5674 |
12:14 ET | 100 | 6.57 |
12:20 ET | 543 | 6.61 |
12:30 ET | 113 | 6.56 |
12:34 ET | 400 | 6.5336 |
12:38 ET | 211 | 6.5744 |
12:39 ET | 400 | 6.5523 |
12:50 ET | 4014 | 6.58 |
12:56 ET | 100 | 6.575 |
12:59 ET | 100 | 6.58 |
01:24 ET | 100 | 6.5701 |
01:30 ET | 900 | 6.5899 |
01:39 ET | 1300 | 6.55 |
01:42 ET | 447 | 6.58 |
01:44 ET | 650 | 6.6149 |
01:55 ET | 1800 | 6.55 |
01:57 ET | 1000 | 6.5759 |
02:08 ET | 200 | 6.55 |
02:11 ET | 262 | 6.57 |
02:18 ET | 100 | 6.5501 |
02:26 ET | 200 | 6.57 |
02:31 ET | 400 | 6.57 |
02:36 ET | 100 | 6.58 |
02:47 ET | 100 | 6.5756 |
02:51 ET | 100 | 6.565 |
02:58 ET | 170 | 6.56 |
03:00 ET | 100 | 6.56 |
03:09 ET | 100 | 6.56 |
03:12 ET | 300 | 6.56 |
03:23 ET | 700 | 6.565 |
03:25 ET | 200 | 6.56 |
03:32 ET | 213 | 6.55 |
03:34 ET | 100 | 6.56 |
03:36 ET | 1535 | 6.56 |
03:38 ET | 200 | 6.59 |
03:41 ET | 1000 | 6.59 |
03:43 ET | 3245 | 6.6 |
03:45 ET | 2464 | 6.64 |
03:48 ET | 100 | 6.6 |
03:50 ET | 1100 | 6.6099 |
03:52 ET | 1798 | 6.6 |
03:56 ET | 1236 | 6.61 |
03:57 ET | 500 | 6.615 |
03:59 ET | 28010 | 6.65 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Candel Therapeutics Inc | 213.4M | -3.9x | --- |
Black Diamond Therapeutics Inc | 211.9M | -2.4x | --- |
Immutep Ltd | 313.4M | -8.6x | --- |
Pyxis Oncology Inc | 210.4M | -2.8x | --- |
Acrivon Therapeutics Inc | 217.1M | -2.5x | --- |
Omeros Corp | 218.5M | -1.1x | --- |
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The Company has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is in ongoing clinical trials in non-small cell lung cancer (NSCLC), borderline resectable pancreatic cancer, and localized, non-metastatic prostate cancer. CAN-3110 is the lead product candidate from the HSV platform and is in an ongoing investigator-sponsored phase I clinical trial in recurrent high-grade glioma (HGG). Its enLIGHTEN Discovery Platform leverages human biology and advanced analytics to create new viral immunotherapies for solid tumors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $213.4M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 32.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.70 |
Book Value | $0.44 |
P/E Ratio | -3.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.